Supernus Pharmaceuticals SUPN Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's common stock, shares, outstanding?
- Supernus Pharmaceuticals (SUPN) reported common stock, shares, outstanding of $58.04M in Q1 2026.
- How has Supernus Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Supernus Pharmaceuticals's common stock, shares, outstanding increased by 3.7% year-over-year, from $55.99M to $58.04M.
- What is the long-term trend for Supernus Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's common stock, shares, outstanding has grown at a 1.7% compound annual growth rate (CAGR), from $52.87M to $57.46M.